Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN26737196) titled 'A 15-week trial to evaluate the SR 5FC formulation vs IR 5FC in cryptococcal meningitis' on Oct. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Single
Purpose: Treatment
Primary Sponsor: Drugs for Neglected Diseases Initiative
Condition:
HIV-associated Cryptococcal Meningitis
Infections and Infestations
Intervention:
Arm 1 (control):
Liposomal amphotericin B (Ambisome, Gilead Sciences) at 10 mg/kg/d iv on day-one, combined with 14 days of both flucytosine (Ancotil, Immediate-release, MEDA Pharma.), 100 mg/kg/d...